Skip to content
DataLookout
Menu

Sandoz clinical trial pipeline

Get alerts when Sandoz's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: HYRISS · Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting Study completion pushed from Dec 2026 to Mar 2027 SandozNot specified NCT05633771
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 3
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Sandoz's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free